What Researchers Did
This review summarized current approaches for managing acute asthma exacerbations in emergency department or clinic settings.
What They Found
High-dose, frequent, or continuous nebulized short-acting beta2 agonists (SABAs), often combined with short-acting muscarinic antagonists (SAMAs), are the primary treatment. Early use of oral or parenteral corticosteroids can reduce the immediate need for ICU or hospital admission. Adjunctive therapies like intravenous magnesium and helium/oxygen should be considered early to impact the patient's clinical course.
What This Means for Canadian Patients
Canadian patients experiencing an acute asthma attack should seek immediate medical attention, as prompt treatment with inhaled medications and potentially corticosteroids can significantly improve outcomes. Early intervention in the emergency department or clinic is crucial to prevent more severe complications like hospitalization.
Canadian Relevance
This study does not have a specific Canadian connection.
Study Limitations
As a clinical review, this study synthesizes existing literature without presenting new primary research data or specific quantitative outcomes.